FDA Selects KP2 as Covid 2024-2025 Vaccine Target. What does that mean for Novavax?

Novavax Covid Vaccine (Fall 2024) Likely Won't be Available in the US, Pending FDA Meeting June 5thПодробнее

Novavax requests FDA authorization for its COVID-19 vaccineПодробнее

FDA authorizes Novavax's COVID vaccineПодробнее

FDA Approves NOVAVAX. Fauci Wants Public To RE-MASK Amid BA.5 SurgeПодробнее

FDA Changes the Fall 2024 Updated Covid-19 Vaccine RecommendationПодробнее

FDA approves new Updated version of COVID vaccineПодробнее

COVID-19 vaccines: FDA gives Moderna's vaccine full approval, Novavax seeks authorizationПодробнее

Novavax CEO: FDA filing for Covid-19 vaccine may happen next weekПодробнее

Novavax Set To Apply For FDA Approval Of COVID-19 VaccineПодробнее

What SARS-CoV-2 Variant Will Be in 2024-2025 COVID-19 Vaccines?Подробнее

FDA Review Finds Pfizer’s Covid Vaccine Is Effective | NBC Nightly NewsПодробнее

New COVID Vaccine and Variants Explained for 2024-25Подробнее

FDA approves Novavax's updated COVID-19 vaccineПодробнее

FDA approves new updated COVID vaccines from Pfizer, ModernaПодробнее

FDA approves new COVID vaccinesПодробнее

FDA testing COVID vaccine alternativeПодробнее

FDA Approves New Covid Vaccines To Target Latest StrainsПодробнее

FDA authorizes newest version of COVID vaccineПодробнее

FDA signs off on new COVID-19 vaccines to target latest variantsПодробнее